From: Sexual function in female juvenile idiopathic arthritis patients
Variables | JIA with sexual dysfunction (n = 3) | JIA without sexual dysfunction (n = 18) | P |
---|---|---|---|
Demographic data | |||
Current age, years | 28 (20–38) | 26.53 (17–38) | 0.600 |
Gynecological features | |||
Menarche age, years | 15 (12–16) | 13 (09–10) | 0.286 |
JIA onset categories | |||
Polyarthritis rheumatoid factor-negative | 3 (100) | 13 (72) | 0.549 |
Systemic | 0 (0) | 3 (17) | 1.000 |
Oligoarthritis | 0 (0) | 2 (11) | 1.000 |
Disease parameters | |||
Number of limited joints | 3.5 (0–32) | 13 (6–39) | 0.078 |
Limitation on motion of hip | 1 (33) | 11 (61) | 0.553 |
Number active joints | 0 (0–2) | 1 (0–12) | 0.566 |
DAS 28, n = 20 | 1.36 (1.05–3.41) | 1.97 (1.05–4.14) | 0.368 |
Acute phase proteins | |||
ESR, mm/1st hour | 07 (03–16) | 8.5 (02–25) | 0.724 |
C-reactive protein, mg/L | 1.9 (1.9–6.3) | 2.3 (0.2–14) | 0.919 |
Current treatment | |||
Prednisone | 1 (33) | 3 (17) | 0.488 |
Methotrexate | 2 (67) | 6 (33) | 0.531 |
Leflunomide | 0 (0) | 6 (33) | 0.526 |
Biological agents | 0 (0) | 9 (50) | 0.227 |